Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines

Introduction Despite the introduction of effective pneumococcal conjugate vaccines (PCV), Streptococcus pneumoniae remains a major cause of acute otitis media (AOM) worldwide. New, higher valency vaccines that offer broader serotype coverage have been recently developed and others are in development...

Full description

Bibliographic Details
Published in:	Expert Review of Vaccines
Main Authors:	Michael Pichichero, Richard Malley, Ravinder Kaur, Robert Zagursky, Porter Anderson
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Subjects:	streptococcus pneumoniae pneumococcal conjugate vaccine acute otitis media epidemiology pneumococcal serotypes
Online Access:	http://dx.doi.org/10.1080/14760584.2023.2162506

Similar Items

Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era
by: Chih-Ho Chen, et al.
Published: (2020-12-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Bacterial Acute Otitis Media Complicated with Otorrhea in a Children’s Hospital in the Era of Pneumococcal Conjugate Vaccines
by: Irene Tzovara, et al.
Published: (2025-05-01)

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines
by: Qian-qian Du, et al.
Published: (2021-12-01)

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
by: Kaile Chen, et al.
Published: (2018-06-01)

Real-World Impact of Pneumococcal Conjugate Vaccines on Vaccine Serotypes and Potential Cross-Reacting Non-Vaccine Serotypes
by: Kevin Apodaca, et al.
Published: (2025-06-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

STREPTOCOCCUS PNEUMONIAE SEROTYPE DISTRIBUTION AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINES
by: Mariya Malcheva
Published: (2019-06-01)

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
by: John Njuma Libwea, et al.
Published: (2020-09-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital
by: Enrique Chacon-Cruz, et al.
Published: (2011-12-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

Systematic review on serotypes distribution of pneumococcal pneumonia in adults and the elderly
by: Fatiha Mrabt, et al.
Published: (2025-03-01)

Global distribution and characteristics of pneumococcal serotypes in adults
by: Haruka Maeda, et al.
Published: (2025-12-01)

Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010–2017
by: Kimiko Ubukata, et al.
Published: (2018-11-01)

The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media
by: Tal Marom, et al.
Published: (2017-10-01)

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
by: Patricia Izurieta, et al.
Published: (2018-06-01)

Molecular characteristics and antimicrobial resistance of invasive pneumococcal isolates from children in the post-13-valent pneumococcal conjugate vaccine era in Shenzhen, China
by: Lu Huang, et al.
Published: (2024-03-01)

Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
by: Hsiao-Chun Chi, et al.
Published: (2018-06-01)

Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
by: Xiuyan Li, et al.
Published: (2023-03-01)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
by: Lucía Fernández-Delgado, et al.
Published: (2021-10-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review
by: Patricia Izurieta, et al.
Published: (2025-05-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study
by: Ma-Chao Li, et al.
Published: (2021-01-01)

Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine
by: Chinelo Ebruke, et al.
Published: (2015-04-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012–2024
by: Tzou-Yien Lin, et al.
Published: (2024-12-01)

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population
by: Stéphane Fiévez, et al.
Published: (2025-08-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
by: Ahmet Arvas, et al.
Published: (2017-08-01)

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis
by: Samuel Darkwah, et al.
Published: (2025-05-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
by: Hye-Young Kim, et al.
Published: (2021-03-01)

One year period of invasive pneumococcal disease in children from a tertiary care hospital in Turkey in the post-vaccine era
by: Gulnihan Ustundag, et al.
Published: (2021-05-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

Serotype 3 pneumococcal pleural empyema: a case report and review of the epidemiology
by: Maja Thoustrup Legardt Johansen, et al.
Published: (2025-12-01)